B'LANCE
LIVE

Serial Number

90491917

Owner

VIVANT BIOTECHNOLOGY GmbH

Attorney

Hui Zhang

Filing Date

Jan 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

B'LANCE Trademark

Serial Number: 90491917 • Registration: 7064715

B'LANCE is a trademark filed by VIVANT BIOTECHNOLOGY GmbH on January 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

VIVANT BIOTECHNOLOGY GmbH (2 trademarks)

Uhlandstr. 33
Berlin 10719 , DE

Entity Type: 16

Trademark Details

Filing Date

January 27, 2021

Registration Date

May 30, 2023

Published for Opposition

March 14, 2023

Goods & Services

Amino acids for medical purposes; Amino acids for veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic substances adapted for medical use; Medicinal drinks; Medicinal infusions for rehydration, nutrition, and the delivery of pharmaceutical preparations to prevent and for the treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency syndrome, neurotransmitter imbalance and long covid; Medicines for human purposes for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and/or drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Pharmaceutical preparations for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency syndrome, neurotransmitter imbalance and long covid; Pharmaceuticals for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Pre-filled Syringes sold filled with hyaluronic acid, pharmaceuticals and supplements, all containing vitamins, amino acids, proteins, creatine, electrolytes, trace elements, coenzymes, vital nutrients, and carbohydrates; Medicated serums for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Sodium salts for medical purposes; Vitamin preparations; Medicinal infusions, namely, intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceuticals and natural remedy preparations for the prevention and treatment of burn-out, PTSD, anxiety, depression, cognitive fatigue, chronic Fatigue, loss in attention, loss in mental concentration, loss in cognitive perception, loss in physical and psychological efficiency and performance and similar stress related disorders, alcohol and drug intoxications and hangover, muscle fatigue after excessive physical stress, Serotonin deficiency Syndrome, neurotransmitter imbalance and long covid; Medicines for human purposes, namely, intravenous bags sold filled with intravenous fluids used for rehydration, nutrition, and the delivery of pharmaceutical preparations for humans; Medicinal infusions, namely, intravenous fluids used for rehydration, nutrition, and the delivery of pharmaceutical preparations for humans

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 30, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
EXAMINERS AMENDMENT MAILED
Feb 8, 2023 CNEA
CASE RETURNED TO EXAMINATION
Feb 8, 2023 OTHE
NOTICE OF ALLOWANCE CANCELLED
Feb 8, 2023 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 1, 2023 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Feb 1, 2023 PCBG
ASSIGNED TO PETITION STAFF
Jan 30, 2023 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Jan 10, 2023 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 8, 2022 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Sep 29, 2022 TMBN
OPPOSITION TERMINATED NO. 999999
Sep 29, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Sep 29, 2022 OP.D
OPPOSITION INSTITUTED NO. 999999
Jun 28, 2022 OP.I
OPPOSITION PAPERS RECEIVED AT TTAB
Jun 28, 2022 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 31, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 31, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 11, 2022 NONP
ASSIGNED TO LIE
Apr 25, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 28, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 15, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 15, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 15, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 15, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 1, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 1, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 29, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2021 NWOS
NEW APPLICATION ENTERED
Jan 30, 2021 NWAP